192 related articles for article (PubMed ID: 7034407)
1. [Antibodies against tumor associated antigens of human bronchogenic carcinoma: demonstration by anti-complement immunofluorescence (author's transl)].
Schlipköter HW; Stiller-Winkler R; Idel H; Knopp J
Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 174(1-2):105-14. PubMed ID: 7034407
[TBL] [Abstract][Full Text] [Related]
2. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
Stiller-Winkler R; Stark M; Idel H
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
[TBL] [Abstract][Full Text] [Related]
3. [Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid].
Dellen H; Seemayer NH
Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Sep; 177(6):451-68. PubMed ID: 6322478
[TBL] [Abstract][Full Text] [Related]
4. The recognition of human bronchogenic carcinomas.
Stark M; Stiller-Winkler R; Idel H; Schlipköter HW
Cancer Detect Prev; 1983; 6(1-2):167-72. PubMed ID: 6883377
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor antibodies in lung cancer patients. Immunofluorescence study using various indicator cells.
Górny MK; Jezewska E; Krzyśko R; Stawarz M; Zeromski J
Neoplasma; 1979; 26(6):729-36. PubMed ID: 396479
[TBL] [Abstract][Full Text] [Related]
6. [Immunological diagnosis of bronchogenic carcinoma (author's transl)].
Schlipköter HW; Idel H; Stiller-Winkler R
Prax Klin Pneumol; 1982 Apr; 36(4):198-201. PubMed ID: 7048283
[No Abstract] [Full Text] [Related]
7. Isolation of lung carcinoma-associated antibodies from immune complexes and production of heterologous antisera.
Cronin WJ; Dorsett BH; Ioachim HL
Cancer Res; 1982 Jan; 42(1):292-300. PubMed ID: 7032694
[TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen in bronchogenic carcinoma.
Zatloukal P; Voslárová Z; Mĕricka O; Svarcová H; Schützner J
Neoplasma; 1987; 34(1):73-6. PubMed ID: 3561607
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a common tumour-associated antigen in extracts of human bronchogenic carcinoma.
Kelly B; Levy JG
Br J Cancer; 1977 Jun; 35(6):828-33. PubMed ID: 871369
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of antibody-dependent cell-mediated cytotoxicity (ADCC) as a means of detection of immune complexes in the sera of patients with thyroid disorders and bronchogenic carcinoma.
Barkas T; AL-Khateeb SF; Irvine WJ; Davidson NM; Roscoe P
Clin Exp Immunol; 1976 Aug; 25(2):270-9. PubMed ID: 986262
[TBL] [Abstract][Full Text] [Related]
11. Partial characterization of a fetal lung antigen associated with human bronchogenic carcinoma.
Sega E; Citro G; Natali PG
J Natl Cancer Inst; 1979 May; 62(5):1125-30. PubMed ID: 108444
[TBL] [Abstract][Full Text] [Related]
12. The use of immunoadsorbent columns for the isolation of antibodies specific for antigens associated with human bronchogenic carcinoma.
Watson RD; Smith AG; Levy JG
Br J Cancer; 1974 Mar; 29(3):183-8. PubMed ID: 4208459
[TBL] [Abstract][Full Text] [Related]
13. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
Pierce GE; DeVald B
Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
[TBL] [Abstract][Full Text] [Related]
14. Antibody specific for lung cancer cells detected in sera of patients with bronchogenic carcinoma.
Yasumoto K; Manabe H; Nomoto K; Inokuchi K
Gan; 1983 Aug; 74(4):595-601. PubMed ID: 6628908
[TBL] [Abstract][Full Text] [Related]
15. [Serologic analysis of tumor antibodies in the sera of patients with carcinoma of the larynx (author's transl)].
Blume N; Milatovic D
Laryngol Rhinol Otol (Stuttg); 1981 Aug; 60(8):405-6. PubMed ID: 7346674
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
Brenner BG; Jothy S; Shuster J; Fuks A
Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
[TBL] [Abstract][Full Text] [Related]
17. Antibody in sera of pulmonary cancer patients against specific surface antigen of oat cells.
Oboshi S; Seido T; Tsugawa S
Gan; 1971 Dec; 62(6):515-22. PubMed ID: 4334635
[No Abstract] [Full Text] [Related]
18. The prognostic value of immunofluorescence from oral swabs in patients with tonsillar carcinoma.
Mang WL; Hammer C
J Med; 1981; 12(6):447-53. PubMed ID: 7033427
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
Dropcho EJ; King PH
Ann Neurol; 1994 Aug; 36(2):200-5. PubMed ID: 8053656
[TBL] [Abstract][Full Text] [Related]
20. Tumour-associated antibodies against renal cell carcinomas detected by immunofluorescence.
Ackermann R
Eur Urol; 1975; 1(3):154-6. PubMed ID: 786650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
